AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
UCN-01 SUPPRESSES THYMIDYLATE SYNTHASE GENE-EXPRESSION AND ENHANCES 5-FLUOROURACIL-INDUCED APOPTOSIS IN A SEQUENCE-DEPENDENT MANNER
Authors: HSUEH CT KELSEN D SCHWARTZ GK
Citation: Ct. Hsueh et al., UCN-01 SUPPRESSES THYMIDYLATE SYNTHASE GENE-EXPRESSION AND ENHANCES 5-FLUOROURACIL-INDUCED APOPTOSIS IN A SEQUENCE-DEPENDENT MANNER, Clinical cancer research, 4(9), 1998, pp. 2201-2206
INTERIM RESULTS OF A PHASE-I TRIAL SUGGESTS THAT TOMUDEX (RALTITREXED) MAY ACT SYNERGISTICALLY WITH 5-FU IN PATIENTS WITH ADVANCED COLORECTAL-CANCER (CRC)
Authors: SCHWARTZ GK BERTINO JL KEMENY N SALTZ L SUGARMAN A KELSEN DK TONG W LOWERY C SMITH M
Citation: Gk. Schwartz et al., INTERIM RESULTS OF A PHASE-I TRIAL SUGGESTS THAT TOMUDEX (RALTITREXED) MAY ACT SYNERGISTICALLY WITH 5-FU IN PATIENTS WITH ADVANCED COLORECTAL-CANCER (CRC), Annals of oncology, 9, 1998, pp. 171-171
INTERIM RESULTS OF PHASE-I TRIAL SUGGESTS THAT TOMUDEX(TM) (RALTRITREXED) MAY ACT SYNERGISTICALLY WITH (5-FLOUROURACIL) 5-FU IN PATIENTS WITH ADVANCED COLORECTAL-CANCER
Authors: SCHWARTZ GK KEMENY N BERTINO J SALTZ L SUGARMAN A KELSEN DK TONG W LOWERY C
Citation: Gk. Schwartz et al., INTERIM RESULTS OF PHASE-I TRIAL SUGGESTS THAT TOMUDEX(TM) (RALTRITREXED) MAY ACT SYNERGISTICALLY WITH (5-FLOUROURACIL) 5-FU IN PATIENTS WITH ADVANCED COLORECTAL-CANCER, Annals of oncology, 9, 1998, pp. 607-607
CHEMOTHERAPY AND P-GLYCOPROTEIN EXPRESSION IN CHONDROSARCOMA
Authors: TEREK RM SCHWARTZ GK DEVANEY K GLANTZ L MAK S HEALEY JH ALBINO AP
Citation: Rm. Terek et al., CHEMOTHERAPY AND P-GLYCOPROTEIN EXPRESSION IN CHONDROSARCOMA, Journal of orthopaedic research, 16(5), 1998, pp. 585-590
PHASE-II TRIAL OF PACLITAXEL IN PATIENTS WITH SOFT-TISSUE SARCOMA
Authors: CASPER ES WALTZMAN RJ SCHWARTZ GK SUGARMAN A PFISTER D ILSON D WOODRUFF J LEUNG D BERTINO JR
Citation: Es. Casper et al., PHASE-II TRIAL OF PACLITAXEL IN PATIENTS WITH SOFT-TISSUE SARCOMA, Cancer investigation, 16(7), 1998, pp. 442-446
LISOFYLLINE SENSITIZES P53 MUTANT HUMAN OVARIAN-CARCINOMA CELLS TO THE CYTOTOXIC EFFECTS OF CIS-DIAMMINEDICHLOROPLATINUM(II)
Authors: HUSAIN A ROSALES N SCHWARTZ GK SPRIGGS DR
Citation: A. Husain et al., LISOFYLLINE SENSITIZES P53 MUTANT HUMAN OVARIAN-CARCINOMA CELLS TO THE CYTOTOXIC EFFECTS OF CIS-DIAMMINEDICHLOROPLATINUM(II), Gynecologic oncology (Print), 70(1), 1998, pp. 17-22
EVIDENCE FOR INVOLVEMENT OF MITOGEN-ACTIVATED PROTEIN-KINASE, RATHER THAN STRESS-ACTIVATED PROTEIN-KINASE, IN POTENTIATION OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE-INDUCED APOPTOSIS BY INTERRUPTION OF PROTEIN-KINASE-C SIGNALING
Authors: JARVIS WD FORNARI FA TOMBES RM ERUKULLA RK BITTMAN R SCHWARTZ GK DENT P GRANT S
Citation: Wd. Jarvis et al., EVIDENCE FOR INVOLVEMENT OF MITOGEN-ACTIVATED PROTEIN-KINASE, RATHER THAN STRESS-ACTIVATED PROTEIN-KINASE, IN POTENTIATION OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE-INDUCED APOPTOSIS BY INTERRUPTION OF PROTEIN-KINASE-C SIGNALING, Molecular pharmacology, 54(5), 1998, pp. 844-856
PMA-INDUCED REDUCTION IN INVASIVENESS IS ASSOCIATED WITH HYPERPHOSPHORYLATION OF MARCKS AND TALIN IN INVASIVE BLADDER-CANCER CELLS
Authors: YOKOYAMA Y ITO T HANSON V SCHWARTZ GK ADEREM AA HOLLAND JF TAMAYA T OHNUMA T
Citation: Y. Yokoyama et al., PMA-INDUCED REDUCTION IN INVASIVENESS IS ASSOCIATED WITH HYPERPHOSPHORYLATION OF MARCKS AND TALIN IN INVASIVE BLADDER-CANCER CELLS, International journal of cancer, 75(5), 1998, pp. 774-779
POTENTIATION OF APOPTOSIS BY FLAVOPIRIDOL IN MITOMYCIN-C-TREATED GASTRIC AND BREAST-CANCER CELLS
Authors: SCHWARTZ GK FARSI K MASLAK P KELSEN DP SPRIGGS D
Citation: Gk. Schwartz et al., POTENTIATION OF APOPTOSIS BY FLAVOPIRIDOL IN MITOMYCIN-C-TREATED GASTRIC AND BREAST-CANCER CELLS, Clinical cancer research, 3(9), 1997, pp. 1467-1472
A PILOT CLINICAL PHARMACOLOGICAL STUDY OF THE PROTEIN-KINASE C-SPECIFIC INHIBITOR SAFINGOL ALONE AND IN COMBINATION WITH DOXORUBICIN/
Authors: SCHWARTZ GK WARD D SALTZ L CASPER ES SPIESS T MULLEN E WOODWORTH J VENUTI R ZERVOS P STORNIOLO AM KELSEN DP
Citation: Gk. Schwartz et al., A PILOT CLINICAL PHARMACOLOGICAL STUDY OF THE PROTEIN-KINASE C-SPECIFIC INHIBITOR SAFINGOL ALONE AND IN COMBINATION WITH DOXORUBICIN/, Clinical cancer research, 3(4), 1997, pp. 537-543
UCN-01 IN OVARY CANCER-CELLS - EFFECTIVE AS A SINGLE-AGENT AND IN COMBINATION WITH CIS-DIAMMINEDICHLOROPLATINUM(II) INDEPENDENT OF P53 STATUS
Authors: HUSAIN A YAN XJ ROSALES N AGHAJANIAN C SCHWARTZ GK SPRIGGS DR
Citation: A. Husain et al., UCN-01 IN OVARY CANCER-CELLS - EFFECTIVE AS A SINGLE-AGENT AND IN COMBINATION WITH CIS-DIAMMINEDICHLOROPLATINUM(II) INDEPENDENT OF P53 STATUS, Clinical cancer research, 3(11), 1997, pp. 2089-2097
CHEMOTHERAPEUTICALLY INDUCED DNA-DAMAGE, ATP DEPLETION, AND THE APOPTOTIC BIOCHEMICAL CASCADE
Authors: MARTIN DS SCHWARTZ GK
Citation: Ds. Martin et Gk. Schwartz, CHEMOTHERAPEUTICALLY INDUCED DNA-DAMAGE, ATP DEPLETION, AND THE APOPTOTIC BIOCHEMICAL CASCADE, Oncology research, 9(1), 1997, pp. 1-5
HIGH-FREQUENCY OF SIMULTANEOUS LOSS OF P16 AND P16-BETA GENE-EXPRESSION IN SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS BUT NOT IN ADENOCARCINOMA OF THE ESOPHAGUS OR STOMACH
Authors: HAYASHI K METZGER R SALONGA D DANENBERG K LEICHMAN LP FINK U SENDLER A KELSEN D SCHWARTZ GK GROSHEN S LENZ HJ DANENBERG PV
Citation: K. Hayashi et al., HIGH-FREQUENCY OF SIMULTANEOUS LOSS OF P16 AND P16-BETA GENE-EXPRESSION IN SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS BUT NOT IN ADENOCARCINOMA OF THE ESOPHAGUS OR STOMACH, Oncogene, 15(12), 1997, pp. 1481-1488
PHASE-I TRIAL OF DOSE-INTENSE LIPOSOME-ENCAPSULATED DOXORUBICIN IN PATIENTS WITH ADVANCED SARCOMA
Authors: CASPER ES SCHWARTZ GK SUGARMAN A LEUNG D BRENNAN MF
Citation: Es. Casper et al., PHASE-I TRIAL OF DOSE-INTENSE LIPOSOME-ENCAPSULATED DOXORUBICIN IN PATIENTS WITH ADVANCED SARCOMA, Journal of clinical oncology, 15(5), 1997, pp. 2111-2117
A PHASE-II STUDY OF TOPOTECAN ADMINISTERED 5 TIMES DAILY IN PATIENTS WITH ADVANCED GASTRIC-CANCER
Authors: SALTZ LB SCHWARTZ GK ILSON DH QUAN V KELSEN DP
Citation: Lb. Saltz et al., A PHASE-II STUDY OF TOPOTECAN ADMINISTERED 5 TIMES DAILY IN PATIENTS WITH ADVANCED GASTRIC-CANCER, American journal of clinical oncology, 20(6), 1997, pp. 621-625
THE NOVEL CYCLIN-DEPENDENT KINASE INHIBITOR FLAVOPIRIDOL DOWN-REGULATES BCL-2 AND INDUCES GROWTH ARREST AND APOPTOSIS IN CHRONIC B-CELL LEUKEMIA LINES
Authors: KONIG A SCHWARTZ GK MOHAMMAD RM ALKATIB A GABRILOVE JL
Citation: A. Konig et al., THE NOVEL CYCLIN-DEPENDENT KINASE INHIBITOR FLAVOPIRIDOL DOWN-REGULATES BCL-2 AND INDUCES GROWTH ARREST AND APOPTOSIS IN CHRONIC B-CELL LEUKEMIA LINES, Blood, 90(11), 1997, pp. 4307-4312
THE PROTEIN-KINASE-C INHIBITOR RO-32-0432 ENHANCES FLUDARABINE-INDUCED APOPTOSIS IN WSU-CLL CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS
Authors: KONIG A SCHWARTZ GK ALKATIB A MOHAMMAD RM HARMON C GABRILOVE JL
Citation: A. Konig et al., THE PROTEIN-KINASE-C INHIBITOR RO-32-0432 ENHANCES FLUDARABINE-INDUCED APOPTOSIS IN WSU-CLL CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS, Blood, 90(10), 1997, pp. 3641-3641
LOSS OF HETEROZYGOSITY AND HOMOZYGOUS DELETION OF THE TPR LOCUS IN HUMAN GASTRIC-CANCER
Authors: CUNNINGHAM JD SCHWARTZ GK KARPEH M BLUNDELL M KELSON DP JHANWAR SC ALBINO AP
Citation: Jd. Cunningham et al., LOSS OF HETEROZYGOSITY AND HOMOZYGOUS DELETION OF THE TPR LOCUS IN HUMAN GASTRIC-CANCER, The American journal of surgery, 173(6), 1997, pp. 521-522
A PHASE-I TRIAL OF A MODIFIED, DOSE-INTENSIVE FAMTX REGIMEN (HIGH-DOSE 5-FLUOROURACIL PLUS DOXORUBICIN PLUS HIGH-DOSE METHOTREXATE PLUS LEUCOVORIN) WITH ORAL URIDINE RESCUE
Authors: SCHWARTZ GK CHRISTMAN K SALTZ L CASPER E QUAN V BERTINO J MARTIN DS COLOFIORE J
Citation: Gk. Schwartz et al., A PHASE-I TRIAL OF A MODIFIED, DOSE-INTENSIVE FAMTX REGIMEN (HIGH-DOSE 5-FLUOROURACIL PLUS DOXORUBICIN PLUS HIGH-DOSE METHOTREXATE PLUS LEUCOVORIN) WITH ORAL URIDINE RESCUE, Cancer, 78(9), 1996, pp. 1988-1995
INHIBITION OF PROTEIN-KINASE-C (PKC) ARRESTS CELL-GROWTH, INDUCES APOPTOSIS, AND ALTERS THE EFFECT OF BASIC FIBROBLAST GROWTH-FACTOR (BFGF)ON BCL-2 EXPRESSION IN CHRONIC LYMPHOID MALIGNANCIES
Authors: KONIG A SCHULZJANDER M SCHWARTZ GK ALKATIB A GABRILOVE JL
Citation: A. Konig et al., INHIBITION OF PROTEIN-KINASE-C (PKC) ARRESTS CELL-GROWTH, INDUCES APOPTOSIS, AND ALTERS THE EFFECT OF BASIC FIBROBLAST GROWTH-FACTOR (BFGF)ON BCL-2 EXPRESSION IN CHRONIC LYMPHOID MALIGNANCIES, Blood, 88(10), 1996, pp. 258-258
POTENTIATION OF APOPTOSIS BY TREATMENT WITH THE PROTEIN-KINASE C-SPECIFIC INHIBITOR SAFINGOL IN MITOMYCIN C-TREATED GASTRIC-CANCER CELLS
Authors: SCHWARTZ GK HAIMOVITZFRIEDMAN A DHUPAR SK EHLEITER D MASLAK P LAI L LOGANZO F KELSEN DP FUKS Z ALBINO AP
Citation: Gk. Schwartz et al., POTENTIATION OF APOPTOSIS BY TREATMENT WITH THE PROTEIN-KINASE C-SPECIFIC INHIBITOR SAFINGOL IN MITOMYCIN C-TREATED GASTRIC-CANCER CELLS, Journal of the National Cancer Institute, 87(18), 1995, pp. 1394-1399
VERY-HIGH-DOSE SHORT-TERM CHEMOTHERAPY FOR POOR-RISK PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMORS, INCLUDING EWINGS-SARCOMA, IN CHILDREN ANDYOUNG-ADULTS
Authors: KUSHNER BH MEYERS PA GERALD WL HEALEY JH LAQUAGLIA MP BOLAND P WOLLNER N CASPER ES ALEDO A HELLER G SCHWARTZ GK BONILLA MA LINDSLEY KL MERCHANT TE ROSENFIELD NS ABRAMSON SJ CHEUNG NKV
Citation: Bh. Kushner et al., VERY-HIGH-DOSE SHORT-TERM CHEMOTHERAPY FOR POOR-RISK PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMORS, INCLUDING EWINGS-SARCOMA, IN CHILDREN ANDYOUNG-ADULTS, Journal of clinical oncology, 13(11), 1995, pp. 2796-2804
A PHASE-II TRIAL OF DOXORUBICIN HCL LIPOSOME INJECTION IN PATIENTS WITH ADVANCED PANCREATIC ADENOCARCINOMA
Authors: SCHWARTZ GK GASPER ES
Citation: Gk. Schwartz et Es. Gasper, A PHASE-II TRIAL OF DOXORUBICIN HCL LIPOSOME INJECTION IN PATIENTS WITH ADVANCED PANCREATIC ADENOCARCINOMA, Investigational new drugs, 13(1), 1995, pp. 77-82
THE MUTATIONAL STATUS OF P53 PROTEIN IN GASTRIC AND ESOPHAGEAL ADENOCARCINOMA CELL-LINES PREDICTS SENSITIVITY TO CHEMOTHERAPEUTIC-AGENTS
Authors: NABEYA Y LOGANZO F MASLAK P LAI L DEOLIVEIRA AR SCHWARTZ GK BLUNDELL ML ALTORKI NK KELSEN DP ALBINO AP
Citation: Y. Nabeya et al., THE MUTATIONAL STATUS OF P53 PROTEIN IN GASTRIC AND ESOPHAGEAL ADENOCARCINOMA CELL-LINES PREDICTS SENSITIVITY TO CHEMOTHERAPEUTIC-AGENTS, International journal of cancer, 64(1), 1995, pp. 37-46
C-SIS AND ONCOGENE EXPRESSION - A FUNDAMENTAL APPROACH TOWARD UNDERSTANDING ESOPHAGEAL CANCER
Authors: SCHWARTZ GK
Citation: Gk. Schwartz, C-SIS AND ONCOGENE EXPRESSION - A FUNDAMENTAL APPROACH TOWARD UNDERSTANDING ESOPHAGEAL CANCER, Cancer investigation, 12(2), 1994, pp. 266-267
Risultati: 1-25 | 26-32